Aurora Financial JournalMiniMed Group, Inc. (MMED)
NASDAQ · Health care · Surgical & Medical Instruments & Apparatus · Financial statements, TTM figures and earnings dates
MiniMed Group, Inc. reported revenue of $3.22B over the trailing twelve months ended July 31, 2026, with net income of −$314.0M. Annual financial statements are available for fiscal years 2024 to 2026, taken from the company's filings with the SEC.
Open interactive financials →Key financials
| USD | TTM 2026-07-31 | FY2026 2026-04-24 | FY2025 2025-04-25 | FY2024 2024-04-26 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $3.22B | $3.10B | $2.71B | $2.47B |
| Gross profit | $1.74B | $1.68B | $1.53B | $1.44B |
| Operating income | −$172.0M | −$190.0M | −$146.0M | −$69.0M |
| Net income | −$314.0M | −$333.0M | −$213.0M | −$112.0M |
| Diluted EPS | −$1.22 | −$1.30 | −$0.84 | −$0.44 |
| Cash flow | ||||
| Operating cash flow | −$105.0M | −$197.0M | $140.0M | $41.0M |
| Capital expenditure | $211.0M | $223.0M | $193.0M | $148.0M |
| Free cash flow | −$316.0M | −$420.0M | −$53.0M | −$107.0M |
| Balance sheet | ||||
| Cash and equivalents | $207.0M | $298.0M | $11.0M | $54.0M |
| Total assets | $4.72B | $4.63B | $4.20B | – |
| Total liabilities | $1.10B | $1.02B | $871.0M | – |
| Shareholders' equity | $3.62B | $3.61B | $3.33B | $3.45B |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in USD as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full MMED page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open MMED financials →